Skip to main content
Clinical Trials/IRCT20230205057333N1
IRCT20230205057333N1RecruitingPhase 3

Assessment of the effect of oral melatonin on the quality of life and sleep and blood pressure of kidney failure patients in the hemodialysis departments of Yasouj city: a randomized clinical trial.

Yasouj University of Medical Sciences0 sites82 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
82

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Age above 18 years
  • Ability to give informed consent
  • The duration of hemodialysis is at least 3 months

Exclusion Criteria

  • Peritoneal Dialysis
  • Known major disease (malignancy, uncontrolled infection, uncontrolled heart failure)
  • Acute medical or surgical illness that requires hospitalization or surgery
  • severe psychological illness (severe depression, psychosis, dementia)
  • History of sensitivity to melatonin

Investigators

Sponsor
Yasouj University of Medical Sciences

Similar Trials